Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › FL › MELBOURNE › VIERA HOSPITAL INC

VIERA HOSPITAL INC

NPI: 1730494816 · MELBOURNE, FL 32940 · General Acute Care Hospital · NPI assigned 08/12/2010

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official PULIO, KRISTEN controls 12+ related entities in our dataset. Read more

$2.04M
Total Medicaid Paid
89,612
Total Claims
74,248
Beneficiaries
88
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialPULIO, KRISTEN (SVP CFO)
NPI Enumeration Date08/12/2010

Related Entities

Other providers sharing the same authorized official: PULIO, KRISTEN

ProviderCityStateTotal Paid
HOLMES REGIONAL MEDICAL CENTER, INC. MELBOURNE FL $12.33M
ADVENTIST HEALTHCARE FORT WASHINGTON MEDICAL CENTER INC FT WASHINGTON MD $8.63M
HOLMES REGIONAL MEDICAL CENTER, INC PALM BAY FL $7.24M
HOSPICE OF HEALTH FIRST INC. WEST MELBOURNE FL $4.13M
CAPE CANAVERAL HOSPITAL, INC. COCOA BEACH FL $3.66M
BLACKWELL PHYSICIANS, LLC ROCKVILLE MD $1.94M
ADVENTIST PHYSICIAN SERVICES, INC. ROCKVILLE MD $405K
ADVENTIST PHYSICIAN SERVICES, INC. TAKOMA PARK MD $79K
HOLMES REGIONAL MEDICAL CENTER, INC. MELBOURNE FL $25K
ADVENTIST PHYSICIAN SERVICES, INC. GERMANTOWN MD $5K
DOCTORS GI PARTNERSHIP LTD PALM BAY FL $932.71
CAPE CANAVERAL HOSPITAL, INC. MELBOURNE FL $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 4,113 $106K
2019 15,245 $226K
2020 13,450 $205K
2021 22,144 $450K
2022 24,113 $624K
2023 9,004 $319K
2024 1,543 $105K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 6,794 5,966 $590K
99283 Emergency department visit for the evaluation and management, moderate severity 6,010 5,520 $526K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 3,261 2,813 $305K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,140 1,054 $94K
80053 Comprehensive metabolic panel 7,573 6,150 $80K
36415 Collection of venous blood by venipuncture 5,181 3,908 $63K
74177 Computed tomography, abdomen and pelvis; with contrast material 1,069 952 $54K
82947 404 294 $41K
70450 Computed tomography, head or brain; without contrast material 1,233 995 $37K
87430 636 607 $25K
74176 Computed tomography, abdomen and pelvis; without contrast material 226 197 $19K
87400 597 536 $18K
71045 Radiologic examination, chest; single view 2,916 2,501 $18K
87088 1,541 1,348 $16K
A9270 Non-covered item or service 7,199 4,217 $15K
81001 3,734 3,261 $13K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 590 535 $12K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 7,642 6,065 $10K
84484 1,760 1,359 $9K
87486 900 845 $9K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2,723 2,256 $8K
J1885 Injection, ketorolac tromethamine, per 15 mg 1,864 1,591 $7K
81003 1,017 905 $6K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 986 921 $6K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 218 200 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 291 227 $5K
71046 Radiologic examination, chest; 2 views 299 270 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,151 1,809 $5K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,458 1,292 $4K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1,014 782 $3K
78815 Positron emission tomography (PET) for limited area imaging 18 15 $2K
81025 1,725 1,595 $2K
93041 1,315 1,118 $2K
59025 Fetal non-stress test 15 12 $2K
80048 Basic metabolic panel (calcium, ionized) 499 391 $2K
94760 431 314 $2K
J2270 Injection, morphine sulfate, up to 10 mg 1,040 824 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 809 743 $2K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 16 14 $2K
94664 215 167 $1K
96361 Intravenous infusion, hydration; each additional hour 338 281 $1K
87210 94 88 $1K
83690 1,553 1,353 $772.90
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 74 66 $730.63
84443 Thyroid stimulating hormone (TSH) 316 267 $691.65
J2704 Injection, propofol, 10 mg 387 336 $655.57
85027 641 536 $652.80
71275 Computed tomographic angiography, chest, with contrast material 15 13 $612.23
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 30 28 $565.84
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 902 845 $534.78
87581 900 845 $451.32
96375 Therapeutic injection; each additional sequential IV push 554 400 $359.91
85610 639 505 $359.03
85730 343 280 $350.13
93975 28 28 $242.47
83735 523 408 $173.29
87186 192 161 $170.83
72125 Computed tomography, cervical spine; without contrast material 17 12 $164.88
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 155 145 $154.87
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 40 39 $147.53
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 155 145 $69.60
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 27 25 $67.91
80061 Lipid panel 58 50 $42.89
83880 80 64 $38.98
84703 392 357 $32.22
87040 61 39 $27.84
83605 205 174 $7.79
84702 49 42 $7.68
86900 128 112 $6.72
87081 585 559 $5.18
86850 17 13 $2.90
86901 128 112 $1.38
88305 Level IV - Surgical pathology, gross and microscopic examination 62 53 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 476 450 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 481 432 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 54 53 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 46 41 $0.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 109 97 $0.00
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 28 26 $0.00
85379 29 28 $0.00
J1790 Injection, droperidol, up to 5 mg 15 12 $0.00
73562 13 13 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 74 64 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 30 27 $0.00
73630 15 14 $0.00
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 16 14 $0.00
87420 14 14 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 14 13 $0.00